WHO ICTRP trial
Efficacy assessment of REpeat intramyocardial INJECTion of autologous bone…
NL-OMON20190 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON20190 |
|---|---|
| Public title | Efficacy assessment of REpeat intramyocardial INJECTion of autologous bone marrow cells in previously responding no-option patients with residual or recurrent refractory Angina Pectoris and documented ischemia. |
| Scientific title | Efficacy assessment of repeat intramyocardial injection of autologous bone marrow cells in previously responding no-option patients with residual or recurrent refractory angina pectoris and documented ischemia. |
| Primary sponsor | Leiden University Medical Center (LUMC), Department of Cardiology |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | refractory angina pectoris bone marrow cell intramyocardial injection |
| Interventions | 1. After written informed consent has been obtained, quality of life and exercise capacity will be investigated. Myocardial perfusion and function will be documented; 2. Bone marrow will be aspired from the iliac crest under local or… |
| Registration date | Dec 23, 2010 |
| Target size | 23 |
| Secondary IDs | NL2546;NTR2664;NL30970.000.10;ISRCTN wordt niet meer aangevraagd. |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: